Weekly News – September 15

Bond King grudge match!

Coming tomorrow: Congress takes on BK

Next sovereign chapter 22?

In defense of litigation funders

Our take:
We are glad to see Judge Preska (SDNY) defend the role of litigation financing. Well-financed adversaries will require deep pockets to see a fight to the end.

Learn more!

Double Dip, double dips and even more double dips!

Exclusive Content

Find it on Reorg here

Find it on Reorg here

How did they do it?

FTX details plan timeline / recovery

Exit financing costs on the rise

Byju’s lenders file suit

Crisis in China

Renaissance speaks up

CPI print

A lot of CRE distress out there…

2023 CRC Allocators Conference coming up in a little more than a month

This event is available to institutional investors only

CRC weighs in on Serta

The Academics Speak Up
Purdue Pharma

Purdue Pharma is the gift that keeps on giving. This is our third installment on the twists and turns this case has taken through the Courts. You can read our first installment here, and our second here.

All bets came off the table when the Supreme Court decided to reshuffle the deck by taking on the appeal of the 2nd Circuitâ€™s decision. Not only did SCOTUS take the unusual step of taking on this big ticket issue in BK cases but it also stopped the lower courtâ€™s decision in its tracks putting the breaks on the entire enchilada. We decided to consult with our expert Academic Contributors for our inaugural feature the Academics Speak Up to get their takes on the latest developments.

We are excited to bring you the varying perspectives of Prof. Tony Casey, Prof. Samir Parikh and Prof. Ralph Brubaker.

Read on here, you wonâ€™t be disappointed.

Read more on Purdue Pharma